Targeted therapy for high-grade glioma with the TGF-?2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.

Source:http://linkedlifedata.com/resource/pubmed/id/20980335

Download in:

View as

General Info

PMID
20980335